Comparison

Anti-Human CD45 (Clone 2D1) - FITC - 500 µg

Item no. LEIN-C895-500ug
Manufacturer Leinco Technologies
Amount 500 ug
Quantity options 100 ug 25 ug 500 ug
Category
Type Antibody Monoclonal
Applications FC, IHC
Clone 2D1
Specific against other
ECLASS 10.1 42030590
ECLASS 11.0 42030590
UNSPSC 12352203
Shipping Condition Cool pack
Available
Manufacturer - Category
Primary Monoclonal Antibodies>SurfaceTag Human CD Markers
Manufacturer - Targets
CD45
Shipping Temperature
2 - 8°C Wet Ice
Storage Conditions
This Fluorescein conjugate is stable when stored at 2-8°C. Do not freeze.
Product Description
CD45 is a receptor protein tyrosine phosphatase involved in immune cell activation1. It is a largeglycoprotein (180-220 kDa) with a broad range of expression in the animal kingdom, includingmammals, chicken, shark, and mosquitoes. The cytoplasmic region of CD45 is highly conservedin mammals but its extracellular region varies between species. Additionally, differential splicingleads to several CD45 isoforms which can vary in glycosylation, which in turn can affect CD45ligand interaction and function. In T cells, isoform expression is dependent on the stage of T cellmaturation, activation, and differentiation.CD45 functions in the immunological synapse of the T cell-antigen presenting cell contact zonethat is formed when T cells encounter cognate antigens presented by major histocompatibility(MHC) molecules 1. CD45 interacts with Src kinases, in particular Lck, to mediate antigenreceptor signaling in T and B cells, and is required for the development and activation oflymphocytes. CD45 also interacts with CD3ζ and CD3ε chains as well as tyrosine kinase Zap 70, DAP12, the Janus kinase family, PAG, CD22, among others. With these interactions, CD45functions to protect the host against viral, bacterial, and fungal infections.Certain variants of CD45 are associated with autoimmune disease and dysregulation is observedin some cancers 1. CD45 has been explored as a target of therapeutic modulation for organtransplantation 1, 2 , autoimmune disease 1, bone marrow transfusion 3, 4, 5, 6 as well as cancerradioimmunotherapy 7, 8, including a bispecific antibody targeting CD45 and 90 Y-DOTA fortherapy of myeloid leukemia 9.2D1 was generated by immunizing BALB/c mice with human peripheral blood mononuclearcells 10, 11. Spleen cells were fused to the P3/NSI/I-Ag4-1 myeloma line and resulting supernatantsscreened by an indirect I125 labeled antiglobulin binding assay.CD45 is also known as leukocyte common antigen (LCA), lymphocyte antigen 5 (Ly-5), andT200 12. 2D1 is also known as anti-HLe-1 10, 11.
Manufacturer - Research Area
Biomarker, Cancer, Immunology
Concentration
0.2 mg/ml
Formulation
This Fluorescein (FITC) conjugate is formulated in 0.01 M phosphate buffered saline (150 mM NaCl) PBS pH 7.4, 1% BSA and 0.09% sodium azide as a preservative.
Antigen Distribution
CD45 is expressed on the surface of all nucleated hematopoietic cells and their precursors, except mature erythrocytes and platelets.

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 500 ug
Available: In stock
available

Delivery expected until 10/30/2025 

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close